Clin2
NCT05022914Possibly a fitRecruiting

PSMA PET/CT scan for PSA relapse after prostate surgery

Prostate CancerBiochemical Relapse Fo Malignant Neoplasm of ProstateProstate AdenocarcinomaProstate Cancer Recurrent

Part of Cancer, Kidney & urinary clinical trials.

This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
180 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You can sign an informed consent form and are age 18 or older
  • You previously had the prostate removed (radical prostatectomy) for prostate adenocarcinoma
  • Your PSA has risen into the relapse range: greater than 0.2 and less than 1
  • You are able to have a 68Ga-PSMA PET/CT scan as part of routine clinical care
  • Your PSA was not still high soon after surgery (within 16 weeks your PSA was 0.1 or less)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06167629Recruiting
PSMA PET scan study for prostate cancer

This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.

Milan
NCT07593079Not yet recruiting· Phase 2
PSMA PET scan for recurrent prostate cancer before radiation

This trial tests whether a special PET scan (called PSMA, which pictures prostate cancer cells) can help doctors better find any remaining or spread of prostate cancer when your PSA level is rising again. It's for people who are planning radiation therapy, and the goal is to see if the scan changes the treatment plan.

St Louis, Missouri
NCT05520255Recruiting· Phase 3
PSMA PET/CT scan to guide care after prostate cancer treatment

This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.

Edmonton, Alberta
NCT04175431Recruiting· Phase 2
PSMA or FACBC PET scan guided treatment for prostate cancer recurrence

This Phase 2 study tests using a special PET/CT scan (PSMA or FACBC) to guide treatment for prostate cancer that has come back after surgery and radiation. The goal is to see whether this scan-based approach can better target cancer in the prostate area (and help plan the right treatment).

Pittsburgh, Pennsylvania
NCT07649122Recruiting· Phase 3
PET Scan Imaging for Prostate Cancer Recurrence Detection

This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.

Nanjing, Jiangsu
NCT06813898Recruiting· Early Phase 1
A New Scan for Early Prostate Cancer Recurrence

This study tests a new scanning method (rhPSMA-7.3 PET/CT) to detect prostate cancer recurrence when PSA is slightly high. If your PSA is low but rising, and standard scans haven't found cancer, this scan might help locate it.

Chicago, Illinois

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.